Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UFG Private Equity is a leading private equity firm that operates as part of the UFG Asset Management group, focusing on investment opportunities in Russia and the CIS region. The firm specializes in providing growth capital and financing buyouts for mid-sized companies across various sectors, with a significant emphasis on healthcare and consumer services. Within the healthcare industry, UFG has been a key investor in private medical providers and pharmaceutical businesses, helping to modernize regional healthcare infrastructure. Their most notable healthcare investment is MD Medical Group, which operates the 'Mother and Child' network of clinics. UFG Private Equity works closely with its portfolio companies to improve corporate governance and drive operational efficiencies. The firm's investment strategy leverages its deep local expertise and international network to identify high-potential assets in the Russian-speaking markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UFG Private Equity.